173 related articles for article (PubMed ID: 23357223)
1. Gene expression signature of human HepG2 cell line.
Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
3. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
4. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
[TBL] [Abstract][Full Text] [Related]
5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
6. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
8. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
Wang SM; Ooi LL; Hui KM
Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
[TBL] [Abstract][Full Text] [Related]
10. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
11. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
14. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
15. Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells.
Lin ZY; Chuang WL
Biomed Pharmacother; 2012 Sep; 66(6):454-8. PubMed ID: 22681909
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
[TBL] [Abstract][Full Text] [Related]
17. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
[TBL] [Abstract][Full Text] [Related]
18. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T
Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P
Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387
[TBL] [Abstract][Full Text] [Related]
20. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
Berger E; Vega N; Vidal H; Geloën A
Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
